GLP-1tirzepatidecontraceptionfertilityglp-1-receptor-agonists

Review flags tirzepatide contraception interaction in GLP-1 reproductive health guidance

Most GLP-1 receptor agonists do not meaningfully alter oral contraceptive pharmacokinetics, but tirzepatide may warrant temporary backup contraception.

By Maren Holt · Senior Reporter, GLP-1

Oct 23 07:00 ETSource: Endocrinology and metabolism clinics of North America

The wire

01A review in Endocrinology and Metabolism Clinics of North America summarizes GLP-1 receptor agonist effects on the hypothalamic-pituitary-ovarian axis, contraception, fertility and pregnancy in women of reproductive age.
02The authors report improved insulin resistance, androgen profiles and possibly menstrual regularity in metabolic ovarian syndrome, a practical counseling point for prescribers treating women of childbearing age.
03Evidence on fertility outcomes and pregnancy safety remains limited, and the piece is a narrative review rather than new trial data.

From the source

GLP-1 Receptor Agonists and Reproductive Health: Implications for Contraception, Fertility, and Pregnancy
Endocrinology and metabolism clinics of North America · 2026 Dec · Porterfield F, Mulligan J, Salim K et al.

Read at pubmed.ncbi.nlm.nih.gov

Source URL https://pubmed.ncbi.nlm.nih.gov/42907053/